Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by harposon May 10, 2017 2:05pm

192 Views

Post# 26227013

MoronicJoe, those are standard disclaimers.

Every company large or small puts in those disclaimers. They declare anything could happen so they will not be held liable if something happens. Theralase lawyers might be even more paranoid than ever since RW said the company is looking forward to reporting out successful results. That may have caused them to go overboard on the disclaimers.
Also, golden, please explain why you believe 2.7 million out of 121000,000 is a high number. I would also love to hear why you believe a less than 3 percent short position holds the stock back.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal